WHO to fast-track availability of diagnostics for Zika virus
Dracunculiasis surveillance programmes respond strongly to rumours, while cases plummet
Medical Product Alert N°2/2016: Falsified AMARIL yellow fever vaccines
World’s largest deworming campaign targets 270 million children in one day
WHO involvement in Zika R&D
Medical Product Alert N°1/2016: Falsified phenobarbitone tablets
Improved availability of new test to enhance global lymphatic filariasis elimination
WHO welcomes new initiative to combat insecticide resistance
WHO statement on the first meeting of the International Health Regulations (2005) (IHR 2005) Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations
WHO Director-General summarizes the outcome of the Emergency Committee regarding clusters of microcephaly and Guillain-Barré syndrome
